FGF7 and breast cancer: Huang et al. showed that inhibiting the effect of circADAM9, which works with similar expression relationships with miR-1236 and fibroblast growth factor 7 (FGF7), in preventing BC progression via the miR-1236-3p/FGF7 axis may be a good target for treatment [42].